# CRINETICS PHARMACEUTICALS IN (CRNX)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CRNX/

- Reporting holders: 272
- Reported value: $4.8B
- Shares held by institutions: 127,552,993 of 106,065,229 outstanding
- Held through calls: 0.1%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [FMR LLC](https://holderbook.com/funds/315066-fmr-llc/) | $592.7M | 15,840,219 | 0.0% | 31 |
| [BlackRock, Inc.](https://holderbook.com/funds/2012383-blackrock-inc/) | $365.2M | 9,758,938 | 0.0% | 8 |
| [FARALLON CAPITAL MANAGEMENT, L.L.C.](https://holderbook.com/funds/909661-farallon-capital-management-l-l-c/) | $336.4M | 8,989,098 | 1.6% | 12 |
| [WELLINGTON MANAGEMENT GROUP LLP](https://holderbook.com/funds/902219-wellington-management-group-llp/) | $266.8M | 7,131,084 | 0.0% | 25 |
| [Driehaus Capital Management LLC](https://holderbook.com/funds/938206-driehaus-capital-management-llc/) | $241.9M | 6,463,551 | 1.4% | 25 |
| [PRICE T ROWE ASSOCIATES INC /MD/](https://holderbook.com/funds/80255-price-t-rowe-associates-inc-md/) | $232.5M | 6,212,681 | 0.0% | 31 |
| [STATE STREET CORP](https://holderbook.com/funds/93751-state-street-corp/) | $201.3M | 5,378,700 | 0.0% | 31 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](https://holderbook.com/funds/2100121-vanguard-portfolio-management-llc/) | $180.8M | 4,832,614 | 0.0% | 2 |
| [VANGUARD CAPITAL MANAGEMENT LLC](https://holderbook.com/funds/2100119-vanguard-capital-management-llc/) | $177.6M | 4,745,262 | 0.0% | 2 |
| [Jupiter Topco LLC](https://holderbook.com/funds/2146052-jupiter-topco-llc/) | $170.5M | 4,557,689 | 0.1% | 1 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $102.1M | 2,727,633 | 0.0% | 31 |
| [Bellevue Group AG](https://holderbook.com/funds/1674546-bellevue-group-ag/) | $98.0M | 2,620,000 | 2.1% | 3 |
| [BAKER BROS. ADVISORS LP](https://holderbook.com/funds/1263508-baker-bros-advisors-lp/) | $88.0M | 2,351,465 | 0.4% | 5 |
| [Polar Capital Holdings Plc](https://holderbook.com/funds/1837309-polar-capital-holdings-plc/) | $85.1M | 2,274,411 | 0.2% | 1 |
| [Pictet Asset Management Holding SA](https://holderbook.com/funds/1993888-pictet-asset-management-holding-sa/) | $77.6M | 2,075,375 | 0.1% | 11 |
| [T. Rowe Price Investment Management, Inc.](https://holderbook.com/funds/1897612-t-rowe-price-investment-management-inc/) | $75.2M | 2,010,288 | 0.0% | 14 |
| [GW&K Investment Management, LLC](https://holderbook.com/funds/1082917-gw-k-investment-management-llc/) | $64.8M | 1,731,140 | 0.5% | 14 |
| [BNP PARIBAS ASSET MANAGEMENT Holding S.A.](https://holderbook.com/funds/1520354-bnp-paribas-asset-management-holding-s-a/) | $62.8M | 1,678,490 | 0.1% | 16 |
| [Siren, L.L.C.](https://holderbook.com/funds/2005245-siren-l-l-c/) | $53.2M | 1,420,788 | 1.1% | 8 |
| [First Light Asset Management, LLC](https://holderbook.com/funds/1600004-first-light-asset-management-llc/) | $50.9M | 1,360,866 | 3.1% | 19 |
| [JPMORGAN CHASE & CO](https://holderbook.com/funds/19617-jpmorgan-chase-co/) | $50.6M | 1,365,030 | 0.0% | 31 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $50.1M | 1,338,531 | 0.0% | 32 |
| [BANK OF AMERICA CORP /DE/](https://holderbook.com/funds/70858-bank-of-america-corp-de/) | $49.9M | 1,333,071 | 0.0% | 31 |
| [NOVO HOLDINGS A/S](https://holderbook.com/funds/1388325-novo-holdings-a-s/) | $49.4M | 1,320,000 | 2.9% | 18 |
| [DIMENSIONAL FUND ADVISORS LP](https://holderbook.com/funds/354204-dimensional-fund-advisors-lp/) | $47.5M | 1,270,531 | 0.0% | 6 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 272 | $4.8B |
| Q1 2026 | 244 | $4.5B |
| Q4 2025 | 247 | $5.3B |
| Q3 2025 | 229 | $4.6B |
| Q2 2025 | 222 | $3.0B |
| Q1 2025 | 227 | $3.4B |
| Q4 2024 | 247 | $5.1B |
| Q3 2024 | 235 | $4.3B |
| Q2 2024 | 235 | $3.8B |
| Q1 2024 | 207 | $3.9B |
| Q4 2023 | 181 | $2.6B |
| Q3 2023 | 175 | $2.1B |